Benefits and Risks of Hormonal Contraception: Has the Attitude Changed? : The Proceedings of an International Symposium, Amsterdam, 19th March, 1982

Haspels, A. A.

ISBN 10: 0852004575 / ISBN 13: 9780852004579

Published by Kluwer Academic Pub, 1982

About this Item

Most of our very good books have only minor imperfections such as shelf wear consistent with a new book that's sat on a bookshop shelf for a year or two. Occasionally we may miss other minor imperfections as we have to grade books at speed. Our books are dispatched from a Yorkshire former cotton mill. We list via barcode/ISBN so please note that the images are stock images and may not be the exact copy you receive, furthermore the details about edition and year might not be accurate as many publishers reuse the same ISBN for multiple editions and as we simply scan a barcode or enter an ISBN we do not check the validity of the edition data when listing. If you're looking for an exact edition please don't order (at least not without checking with us first, although we don't always have time to check). We aim to dispatch prompty, the service used will depend on order value and book size. We can ship to most countries, see our shipping policies. Payment is via Abe only.

Seller Inventory # L-BEI00982-RAG-20250520-VG

Bibliographic Details

• Title: Benefits and Risks of Hormonal Contraception: Has the Attitude Changed? : The Proceedings of an International Symposium, Amsterdam, 19th March, 1982
• Publisher: Kluwer Academic Pub
• Publication Date: 1982
• Language: English
• ISBN 10: 0852004575
• ISBN 13: 9780852004579
• Binding: hardcover
• Condition: Very Good

About this title

Synopsis

A. A. Haspe/s It is with pleasure that I welcome you, on behalf of Professor Rolland and myself, to Amsterdam for this International Symposium on 'Benefits and Risks of Hormonal Contraception'. As a means offamily planning the pill is about 25 years old - a timespan which has been characterized by an enormous increase in public interest and concern with family health and family-planning. Undoubtedly we have learned a lot over the last 25 years. As you see in Figure 1, in the seventies in Holland relatively more fertile women used the pill than in any other country in the world. In 1974 new combination pills were introduced containing less than 50 JAg of ethinyl estradiol. In 1981 50 % of Dutch pill­ users took a sub-50 (Figure 2). The same is true for the Scandi­ navian countries. In our own University Clinic 95 % of pill-users take a sub-50 pill; only 5 % use a 50 JAg pill on medical indication. This decrease in estrogen dosage, which is usually accompanied by a decrease of progestational component as well, has resulted in a decrease of thromboembolic disease. Factors that are still important to consider are diabetes mellitus, hypertension, adipositas and smoking. Good selection of patients together with the prescribing where possible of sub-50 pills may result in the numbers of compli­ cations and side-effects being close to those encountered in the control group.